Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

LATEST INFECTIOUS DISEASE ARTICLES

RSS Latest Infectious Disease Articles
  • Otitis Media in Young Children April 10, 2025
    Acute otitis media occurs almost exclusively after a viral upper respiratory tract infection. Children with mild or moderate symptoms can be treated with antibiotics or closely observed.
    Nader Shaikh
  • NEJM Outbreaks Update — H5N1: A View from the States April 3, 2025
    In this NEJM Outbreaks Update, Editor-in-Chief Eric Rubin and Deputy Editor Lindsey Baden are joined by state public health leaders Robbie Goldstein and Jennifer Shuford to discuss action against H5N1 in Massachusetts and Texas and across the nation.
    Eric J. Rubin, Lindsey R. Baden, Robert Goldstein, Jennifer A. Shuford, Stephen Morrissey
  • Working at Cross-PURPOSEs to Ending HIV April 3, 2025
    Almost 15 years ago, the results of the Preexposure Prophylaxis Initiative (iPrEx) trial, which showed the efficacy of oral antiretroviral agents as preexposure prophylaxis (PrEP), were reported in the Journal.1 However, only 15% of persons who would benefit from PrEP currently receive it.2 The...
    Glenda E. Gray, W.D. Francois Venter

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.